GVH fines Sager Pharma HUF 10 mln
pixabay
The Hungarian Competition Authority (GVH) fined pharmaceutical company Sager Pharma HUF 10 million on charges of misleading advertising in regards to the effects of product Seractil Dolo 300mg, GVH said today, according to Hungarian news agency MTI.
According to the authority, the company made misleading statements about the product taking effect immediately after consumption, while some time is needed for the body to absorb the medicine in actuality, the news agency reported.
The authority added that it expects companies to apply the medically approved methods of usage of a given product when designing the productĘĽs advertising, MTI said.
ADVERTISEMENT
Hungary Agricultural Output Value Grows by 6.5%
Hungarian-American Business Chamber Established in Chicago
Number of Registered Jobseekers Down 3% in November
Mulled Version of Belle-Vue Kriek Makes Debut at Advent Fair
SUPPORT THE BUDAPEST BUSINESS JOURNAL
Producing journalism that is worthy of the name is a costly business. For 27 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.
